Raymond Bergan

Professor

  • 3918 Citations
  • 37 h-Index
1977 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2019

Genistein treatment duration effects biomarkers of cell motility in human prostate

Zhang, H., Gordon, R., Li, W., Yang, X., Pattanayak, A., Fowler, G., Zhang, L., Catalona, W. J., Ding, Y., Xu, L., Huang, X., Jovanovic, B., Kelly, D. L., Jiang, H. & Bergan, R., Mar 2019, In : PloS one. 14, 3, e0214078.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells

Li, Y., Guo, Y., Feng, Z., Bergan, R., Li, B., Qin, Y., Zhao, L., Zhang, Z. & Shi, M., Jan 1 2019, In : Nutrition and Cancer.

Research output: Contribution to journalArticle

2 Scopus citations

Modeling MEK4 Kinase Inhibitors through Perturbed Electrostatic Potential (ESP) Charges

Mishra, R. K., Deibler, K. K., Clutter, M. R., Vagadia, P. P., O'Connor, M., Schiltz, G. E., Bergan, R. & Scheidt, K. A., Jan 1 2019, (Accepted/In press) In : Journal of Chemical Information and Modeling.

Research output: Contribution to journalArticle

Rapid fabrication of vascularized and innervated cell-laden bone models with biomimetic intrafibrillar collagen mineralization

Thrivikraman, G., Athirasala, A., Gordon, R., Zhang, L., Bergan, R., Keene, D. R., Jones, J. M., Xie, H., Chen, Z., Tao, J., Wingender, B., Gower, L., Ferracane, J. & Bertassoni, L., Dec 1 2019, In : Nature communications. 10, 1, 3520.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations

Synthesis and Biological Evaluation of 3-Arylindazoles as Selective MEK4 Inhibitors

Deibler, K. K., Schiltz, G. E., Clutter, M. R., Mishra, R. K., Vagadia, P. P., O'Connor, M., George, M. D., Gordon, R., Fowler, G., Bergan, R. & Scheidt, K. A., Mar 22 2019, In : ChemMedChem. 14, 6, p. 615-620 6 p.

Research output: Contribution to journalArticle

1 Scopus citations

Whole-body imaging of cell death provides a systemic, minimally invasive, dynamic, and near-real time indicator for chemotherapeutic drug toxicity

Johnson, S. E., Ugolkov, A., Haney, C. R., Bondarenko, G., Li, L., Waters, E. A., Bergan, R., Tran, A., O'Halloran, T. V., Mazar, A. & Zhao, M., Feb 15 2019, In : Clinical Cancer Research. 25, 4, p. 1331-1342 12 p.

Research output: Contribution to journalArticle

2 Scopus citations
2018

DNA repair gene alterations and PARP inhibitor response in patients with metastatic castration-resistant prostate cancer

Lu, E., Thomas, G. V., Chen, Y., Wyatt, A. W., Lloyd, P., Youngren, J., Quigley, D., Bergan, R., Bailey, S., Beer, T. M., Feng, F. Y., Small, E. J. & Alumkal, J. J., Aug 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 8, p. 933-937 5 p.

Research output: Contribution to journalArticle

2 Scopus citations
6 Scopus citations

Precision therapeutic targeting of human cancer cell motility

Xu, L., Gordon, R., Farmer, R., Pattanayak, A., Binkowski, A., Huang, X., Avram, M., Krishna, S., Voll, E., Pavese, J., Chavez, J., Bruce, J., Mazar, A., Nibbs, A., Anderson, W., Li, L., Jovanovic, B., Pruell, S., Valsecchi, M., Francia, G. & 3 others, Betori, R., Scheidt, K. & Bergan, R., Dec 1 2018, In : Nature communications. 9, 1, 2454.

Research output: Contribution to journalArticle

10 Scopus citations

Prevention of colonic neoplasia with polyethylene glycol: A short term randomized placebo-controlled double-blinded trial

Wali, R. K., Bianchi, L., Kupfer, S., De La Cruz, M., Jovanovic, B., Weber, C., Goldberg, M. J., Rodriguez, L. M., Bergan, R., Rubin, D., Tull, M. B., Richmond, E., Parker, B., Khan, S. & Roy, H. K., Apr 1 2018, In : PLoS One. 13, 4, e0193544.

Research output: Contribution to journalArticle

1 Scopus citations
2017

A Chemical Probe Strategy for Interrogating Inhibitor Selectivity Across the MEK Kinase Family

Deibler, K. K., Mishra, R. K., Clutter, M. R., Antanasijevic, A., Bergan, R., Caffrey, M. & Scheidt, K. A., May 19 2017, In : ACS Chemical Biology. 12, 5, p. 1245-1256 12 p.

Research output: Contribution to journalArticle

3 Scopus citations

Selenomethionine and methyl selenocysteine: Multiple-dose pharmacokinetics in selenium-replete men

Marshall, J. R., Burk, R. F., Ondracek, R. P., Hill, K. E., Perloff, M., Davis, W., Pili, R., George, S. & Bergan, R., Jan 1 2017, In : Oncotarget. 8, 16, p. 26312-26322 11 p.

Research output: Contribution to journalArticle

9 Scopus citations

Spectral biomarkers for chemoprevention of colonic neoplasia: A placebo-controlled double-blinded trial with aspirin

Roy, H. K., Turzhitsky, V., Wali, R., Radosevich, A. J., Jovanovic, B., Della'Zanna, G., Umar, A., Rubin, D. T., Goldberg, M. J., Bianchi, L., De La Cruz, M., Bogojevic, A., Helenowski, I. B., Rodriguez, L., Chatterton, R., Skripkauskas, S., Page, K., Weber, C. R., Huang, X., Richmond, E. & 2 others, Bergan, R. C. & Backman, V., Feb 1 2017, In : Gut. 66, 2, p. 285-292 8 p.

Research output: Contribution to journalArticle

15 Scopus citations
2016

Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer

Graff, J., Alumkal, J., Drake, C. G., Thomas, G., Redmond, W. L., Farhad, M., Cetnar, J., Ey, F. F., Bergan, R., Slottke, R. & Beer, T. T., Aug 1 2016, In : Oncotarget. 7, 33, p. 52810-52817 8 p.

Research output: Contribution to journalArticle

169 Scopus citations
2015

Blood Telomere Length Attrition and Cancer Development in the Normative Aging Study Cohort

Hou, L., Joyce, B. T., Gao, T., Liu, L., Zheng, Y., Penedo, F. J., Liu, S., Zhang, W., Bergan, R., Dai, Q., Vokonas, P., Hoxha, M., Schwartz, J. & Baccarelli, A., Jun 1 2015, In : EBioMedicine. 2, 6, p. 591-596 6 p.

Research output: Contribution to journalArticle

40 Scopus citations

Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis

Xiao, X., Liu, Z., Wang, R., Wang, J., Zhang, S., Cai, X., Wu, K., Bergan, R. C., Xu, L. & Fan, D., Jan 1 2015, In : Oncotarget. 6, 5, p. 3225-3239 15 p.

Research output: Contribution to journalArticle

Open Access
32 Scopus citations
2014

A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in Situ of the breast

Lee, O., Page, K., Ivancic, D., Helenowski, I., Parini, V., Sullivan, M. E., Margenthaler, J. A., Chatterton, R. T., Jovanovic, B., Dunn, B. K., Heckman-Stoddard, B. M., Foster, K., Muzzio, M., Shklovskaya, J., Skripkauskas, S., Kulesza, P., Green, D., Hansen, N. M., Bethke, K. P., Jeruss, J. S. & 2 others, Bergan, R. & Khan, S. A., Jul 15 2014, In : Clinical Cancer Research. 20, 14, p. 3672-3682 11 p.

Research output: Contribution to journalArticle

26 Scopus citations

Circulating giant macrophages as a potential biomarker of solid tumors

Adams, D. L., Martin, S. S., Alpaugh, R. K., Charpentier, M., Tsai, S., Bergan, R. C., Ogden, I. M., Catalona, W., Chumsri, S., Tang, C. M. & Cristofanilli, M., Mar 4 2014, In : Proceedings of the National Academy of Sciences of the United States of America. 111, 9, p. 3514-3519 6 p.

Research output: Contribution to journalArticle

86 Scopus citations

Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapy

Pavese, J. M. & Bergan, R. C., Oct 1 2014, In : Cancer Letters. 352, 2, p. 179-186 8 p.

Research output: Contribution to journalArticle

26 Scopus citations

Diminished expression of h2-calponin in prostate cancer cells promotes cell proliferation, migration and the dependence of cell adhesion on substrate stiffness

Moazzem Hossain, M., Wang, X., Bergan, R. C. & Jin, J. P., 2014, In : FEBS Open Bio. 4, p. 627-636 10 p.

Research output: Contribution to journalArticle

17 Scopus citations

Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis

Pavese, J. M., Krishna, S. N. & Bergan, R. C., Jul 1 2014, In : American Journal of Clinical Nutrition. 100, SUPPL. 1, p. 431S-436S

Research output: Contribution to journalArticle

49 Scopus citations

Heat shock protein 27 regulates human prostate cancer cell motility and metastatic progression

Voll, E. A., Ogden, I. M., Pavese, J. M., Huang, X. K., Xu, L., Jovanovic, B. D. & Bergan, R. C., 2014, In : Oncotarget. 5, 9, p. 2648-2663 16 p.

Research output: Contribution to journalArticle

Open Access
29 Scopus citations

Improving diversity in cancer research trials: The story of the cancer disparities research network

Simon, M. A., De La Riva, E. E., Bergan, R., Norbeck, C., McKoy, J. M., Kulesza, P., Dong, X. Q., Schink, J. & Fleisher, L., Jun 2014, In : Journal of Cancer Education. 29, 2, p. 366-374 9 p.

Research output: Contribution to journalArticle

11 Scopus citations

Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis

Pavese, J. M., Ogden, I. M., Voll, E. A., Huang, X., Xu, L., Jovanovic, B. & Bergan, R. C., Jul 14 2014, In : PloS one. 9, 7, e102289.

Research output: Contribution to journalArticle

21 Scopus citations
2013

A fluorescence-based thermal shift assay identifies inhibitors of mitogen activated protein kinase kinase 4

Krishna, S. N., Luan, C. H., Mishra, R. K., Xu, L., Scheidt, K. A., Anderson, W. F. & Bergan, R. C., Dec 5 2013, In : PloS one. 8, 12, e81504.

Research output: Contribution to journalArticle

22 Scopus citations

Androgen receptor-independent function of FoxA1 in prostate cancer metastasis

Jin, H. J., Zhao, J. C., Ogden, I., Bergan, R. C. & Yu, J., Jun 15 2013, In : Cancer Research. 73, 12, p. 3725-3736 12 p.

Research output: Contribution to journalArticle

74 Scopus citations

An orthotopic murine model of human prostate cancer metastasis.

Pavese, J., Ogden, I. M. & Bergan, R. C., 2013, In : Journal of visualized experiments : JoVE. 79, p. e50873

Research output: Contribution to journalArticle

18 Scopus citations

A phase i trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia

Wong, S. J., Campbell, B., Massey, B., Lynch, D. P., Cohen, E. E. W., Blair, E., Selle, R., Shklovskaya, J., Jovanovic, B. D., Skripkauskas, S., Dew, A., Kulesza, P., Parimi, V., Bergan, R. C. & Szabo, E., Sep 1 2013, In : Oral Oncology. 49, 9, p. 970-976 7 p.

Research output: Contribution to journalArticle

14 Scopus citations

Crystal structure of a type II dehydroquinate dehydratase-like protein from Bifidobacterium longum

Light, S. H., Krishna, S. N., Bergan, R. C., Lavie, A. & Anderson, W. F., Mar 1 2013, In : Journal of Structural and Functional Genomics. 14, 1, p. 25-30 6 p.

Research output: Contribution to journalArticle

Endoglin-Mediated Suppression of Prostate Cancer Invasion Is Regulated by Activin and Bone Morphogenetic Protein Type II Receptors

Breen, M. J., Moran, D. M., Liu, W., Huang, X., Vary, C. P. H. & Bergan, R. C., Aug 13 2013, In : PloS one. 8, 8, e72407.

Research output: Contribution to journalArticle

15 Scopus citations

Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial

Dew, A., Khan, S., Babinski, C., Michel, N., Heffernan, M., Stephan, S., Jordan, N., Jovanovic, B., Carney, P. & Bergan, R., Apr 1 2013, In : Clinical Trials. 10, 2, p. 292-299 8 p.

Research output: Contribution to journalArticle

9 Scopus citations
2012

Soy isoflavone supplementation for breast cancer risk reduction: A randomized phase ii trial

Khan, S. A., Chatterton, R. T., Michel, N., Bryk, M., Lee, O., Ivancic, D., Heinz, R., Zalles, C. M., Helenowski, I. B., Jovanovic, B. D., Franke, A. A., Bosland, M. C., Wang, J., Hansen, N. M., Bethke, K. P., Dew, A., Coomes, M. & Bergan, R. C., Feb 1 2012, In : Cancer Prevention Research. 5, 2, p. 309-319 11 p.

Research output: Contribution to journalArticle

99 Scopus citations
2011

Endoglin regulates cancer-stromal cell interactions in prostate tumors

Romero, D., O'Neill, C., Terzic, A., Contois, L., Young, K., Conley, B. A., Bergan, R. C., Brooks, P. C. & Vary, C. P. H., May 15 2011, In : Cancer Research. 71, 10, p. 3482-3493 12 p.

Research output: Contribution to journalArticle

38 Scopus citations

Endoglin suppresses human prostate cancer metastasis

Lakshman, M., Huang, X., Ananthanarayanan, V., Jovanovic, B., Liu, Y., Craft, C. S., Romero, D., Vary, C. P. H. & Bergan, R. C., Jan 1 2011, In : Clinical and Experimental Metastasis. 28, 1, p. 39-53 15 p.

Research output: Contribution to journalArticle

31 Scopus citations

Methyl selenocysteine: Single-dose pharmacokinetics in men

Marshall, J. R., Ip, C., Romano, K., Fetterly, G., Fakih, M., Jovanovic, B., Perloff, M., Crowell, J., Davis, W., French-Christy, R., Dew, A., Coomes, M. & Bergan, R., Nov 1 2011, In : Cancer Prevention Research. 4, 11, p. 1938-1944 7 p.

Research output: Contribution to journalArticle

22 Scopus citations

The Ninth Annual American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research

Xu, L., Wang, S. S., Healey, M. A., Faupel-Badger, J. M., Wilken, J. A., Battaglia, T., Szabo, E., Mao, J. T. & Bergan, R. C., Apr 1 2011, In : Cancer Prevention Research. 4, 4, p. 616-621 6 p.

Research output: Contribution to journalArticle

2 Scopus citations
2010

Concise syntheses of the abyssinones and discovery of new inhibitors of prostate cancer and MMP-2 expression

Farmer, R. L., Biddle, M. M., Nibbs, A. E., Huang, X., Bergan, R. C. & Scheidt, K. A., Nov 11 2010, In : ACS Medicinal Chemistry Letters. 1, 8, p. 400-405 6 p.

Research output: Contribution to journalArticle

28 Scopus citations

Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migration

Romero, D., Terzic, A., Conley, B. A., Craft, C. S., Jovanovic, B., Bergan, R. C. & Vary, C. P. H., Mar 1 2010, In : Carcinogenesis. 31, 3, p. 359-366 8 p.

Research output: Contribution to journalArticle

23 Scopus citations
2009

Labeling TiO2 nanoparticles with dyes for optical fluorescence microscopy and determination of TiO2-DNA nanoconjugate stability

Thurn, K. T., Paunesku, T., Wu, A., Brown, E. M. B., Lai, B., Vogt, S., Maser, J., Aslam, M., Dravid, V., Bergan, R. & Woloschak, G. E., Jun 5 2009, In : Small. 5, 11, p. 1318-1325 8 p.

Research output: Contribution to journalArticle

71 Scopus citations

MEK4 function, genistein treatment, and invasion of human prostate cancer cells

Xu, L., Ding, Y., Catalona, W. J., Yang, X. J., Anderson, W. F., Jovanovic, B., Wellman, K., Killmer, J., Huang, X., Scheidt, K. A., Montgomery, R. B. & Bergan, R. C., Aug 1 2009, In : Journal of the National Cancer Institute. 101, 16, p. 1141-1155 15 p.

Research output: Contribution to journalArticle

65 Scopus citations
2008

Dietary genistein inhibits metastasis of human prostate cancer in mice

Lakshman, M., Xu, L., Ananthanarayanan, V., Cooper, J., Takimoto, C. H., Helenowski, I., Pelling, J. C. & Bergan, R. C., Mar 15 2008, In : Cancer Research. 68, 6, p. 2024-2032 9 p.

Research output: Contribution to journalArticle

125 Scopus citations

Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images

Paunesku, T., Ke, T., Dharmakumar, R., Mascheri, N., Wu, A., Lai, B., Vogt, S., Maser, J., Thurn, K., Szolc-Kowalska, B., Larson, A., Bergan, R. C., Omary, R., Li, D., Lu, Z. R. & Woloschak, G. E., Sep 1 2008, In : Nanomedicine: Nanotechnology, Biology, and Medicine. 4, 3, p. 201-207 7 p.

Research output: Contribution to journalArticle

39 Scopus citations

Genistein induces phenotypic reversion of endoglin deficiency in human prostate cancer cells

Craft, C. S., Xu, L., Romero, D., Vary, C. P. H. & Bergan, R. C., Jan 1 2008, In : Molecular pharmacology. 73, 1, p. 235-242 8 p.

Research output: Contribution to journalArticle

25 Scopus citations

Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells

Mirzoeva, S., Nam, D. K., Chiu, K., Franzen, C. A., Bergan, R. C. & Pelling, J. C., Sep 1 2008, In : Molecular Carcinogenesis. 47, 9, p. 686-700 15 p.

Research output: Contribution to journalArticle

68 Scopus citations
2007

A phase II study of single agent bortezomib in patients with metastatic breast cancer: A single institution experience

Engel, R. H., Brown, J. A., Von Roenn, J. H., O'Regan, R. M., Bergan, R., Badve, S., Rademaker, A. & Gradishar, W. J., Dec 1 2007, In : Cancer Investigation. 25, 8, p. 733-737 5 p.

Research output: Contribution to journalArticle

51 Scopus citations

Associations of serum carotenoid levels with serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels in black men and white men

Kim, Y. L., Jacobs, D. R., Gross, M. D., Bergan, R. C., Gann, P. H., Liu, K. & Gapstur, S. M., Dec 1 2007, In : Cancer Epidemiology Biomarkers and Prevention. 16, 12, p. 2781-2783 3 p.

Research output: Contribution to journalArticle

1 Scopus citations

Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway

Craft, C. S., Romero, D., Vary, C. P. H. & Bergan, R. C., Nov 8 2007, In : Oncogene. 26, 51, p. 7240-7250 11 p.

Research output: Contribution to journalArticle

48 Scopus citations

The methodology used to measure differential gene expression affects the outcome

Ding, Y., Xu, L., Jovanovic, B. D., Helenowski, I. B., Kelly, D. L., Catalona, W. J., Yang, X. J., Pins, M. & Bergan, R. C., Dec 1 2007, In : Journal of Biomolecular Techniques. 18, 5, p. 321-330 10 p.

Research output: Contribution to journalArticle

22 Scopus citations
2006

Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification

Ding, Y., Xu, L., Chen, S., Jovanovic, B. D., Helenowski, I. B., Kelly, D. L., Catalona, W. J., Yang, X. J., Pins, M., Ananthanarayanan, V. & Bergan, R. C., Dec 1 2006, In : Prostate Cancer and Prostatic Diseases. 9, 4, p. 379-391 13 p.

Research output: Contribution to journalArticle

16 Scopus citations
62 Scopus citations